Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro
PLOS ONE · 16.02.2024 · 19 (2) · e0297291
DOI: 10.1371/journal.pone.0297291 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 16.02.2024. Verfasst von Marina Rius-Salvador und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Bioquímica i Biologia Molecular, Institut Universitari de Biotecnologia i Biomedicina (BIOTECMED), Universitat de València, Burjassot,…. Hauptthemen laut MEDLINE: Anti-Infective Agents, Local, Influenza A virus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The oral cavity is the site of entry and replication for many respiratory viruses. Furthermore, it is the source of droplets and aerosols that facilitate viral transmission. It is thought that appropriate oral hygiene that alters viral infectivity might reduce the spread of respiratory viruses and contribute to infection control. Materials and methods Here, we analyzed the antiviral activity of cetylpyridinium chloride (CPC), chlorhexidine (CHX), and three commercial CPC and CHX-containing mouthwash preparations against the Influenza A virus and the Respiratory syncytial virus. To do so the aforementioned compounds and preparations were incubated with the Influenza A virus or with the Respiratory syncytial virus. Next, we analyzed the viability of the treated viral particles.
Results
Our results indicate that CPC and CHX decrease the infectivity of both the Influenza A virus and the Respiratory Syncytial virus in vitro between 90 and 99.9% depending on the concentration. Likewise, CPC and CHX-containing mouthwash preparations were up to 99.99% effective in decreasing the viral viability of both the Influenza A virus and the Respiratory syncytial virus in vitro .
Conclusion
The use of a mouthwash containing CPC or CHX alone or in combination might represent a cost-effective measure to limit infection and spread of enveloped respiratory viruses infecting the oral cavity, aiding in reducing viral transmission. Our findings may stimulate future clinical studies to evaluate the effects of CPC and CHX in reducing viral respiratory transmissions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departament de Bioquímica i Biologia Molecular, Institut Universitari de Biotecnologia i Biomedicina (BIOTECMED), Universitat de València, Burjassot, Spain.
- Institute for Integrative Systems Biology (I2SysBio), UV-CSIC, Paterna, Spain.
- Department of Microbiology, DENTAID Research Center, Cerdanyola del Vallès, Spain.
ORCID-Profile: Ron Geller, Luis Martinez-Gil
Zitieren
APA
Rius-Salvador, M., García-Múrria, M. J., Rusu, L., Bañó-Polo, M., León, R., Geller, R., Mingarro, I., & Martinez-Gil, L. (2024). Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro. PLOS ONE, 19(2), e0297291. https://doi.org/10.1371/journal.pone.0297291
Vancouver
Rius-Salvador M, García-Múrria MJ, Rusu L, Bañó-Polo M, León R, Geller R, et al. Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro. PLOS ONE. 2024;19(2):e0297291. doi:10.1371/journal.pone.0297291
BibTeX
@article{RiusSalvador2024,
author = {Rius-Salvador, Marina and García-Múrria, Maria Jesús and Rusu, Luciana and Bañó-Polo, Manuel and León, Rubén and Geller, Ron and Mingarro, Ismael and Martinez-Gil, Luis},
title = {Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {2},
pages = {e0297291},
doi = {10.1371/journal.pone.0297291}
}
EUVIMED